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ABSTRACT Overwhelminginﬂammationtriggeredbysystemicinfectioninbacterialsepsiscontributestothepathologyofthis
condition.Toll-likereceptors(TLRs)areimportantinearlysepticinﬂammation.Asasafeguard,theinnateimmunesystemhas
evolvedtocounterexcessiveinﬂammationthroughtheinductionof“tolerance.”Inendotoxintolerance,TLRsignalingisinhib-
itedand/orattenuatedbymultiplemechanismsthatmitigatetheabilityoflipopolysaccharide(LPS)toactivatecriticalkinases
throughTLR4.Here,wedescribeanovelmechanism.ProteinkinaseR(PKR),akinasenormallyactivatedbyasubsetofTLRs,is
renderedunresponsivetoLPSinendotoxin-tolerizedcells.Initsnaivestate,PKRissubjecttoK63-linkedubiquitination(Ub),
followedbyK48-linkedUb,inresponsetoLPS.Intolerance,thekineticsofthisdifferentialUbisaltered,resultinginapredomi-
nanceofK48-linkedchains,concomitantwithalossofPKRactivation.Theseﬁndingsprovideanovelmechanismbywhicha
TLR-responsivekinasemayberenderedinactiveintolerance.
IMPORTANCE “Endotoxintolerance”isaperiodoftransientunresponsivenesstothelipopolysaccharide(LPS)outermembrane
componentofGram-negativebacteriathatisinducedbypriorexposuretoLPSthroughToll-likereceptor4(TLR4).Thelossof
LPS-induciblecytokineproductionbymacrophagesfrompatientswhohaveexperiencedGram-negativesepsisiswelldocu-
mented,andtheincreasedsusceptibilityofsuchpatientstoreinfectionhasbeenattributedtothedevelopmentofendotoxintol-
erance.Multiplemechanismshavebeenprofferedtoaccountforthisattenuatedresponse.UsingtheLPS-responsivekinasepro-
teinkinaseR(PKR),wehaveidentiﬁeddifferentialK48versusK63ubiquitinationasanadditionalmolecularmechanismby
whichsignal-transducingelementsmaybeinactivatedinastateofendotoxintolerance.Thisworkishighlysigniﬁcantbecauseit
linksrecentdiscoveriesconcerningtheimportantroleofubiquitinationofsignalingmoleculesinregulatingTLRsignalingwith
thelossofLPSresponsivenessintolerance.
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T
he successful resolution of microbial infection in mammals
initially requires a robust proinﬂammatory response that in-
volves the synthesis and action of cytokines and chemokines, as
well as agents with direct antimicrobial activities. These inﬂam-
matory mediators function by inﬂuencing and coordinating the
behavior of a vast array of physiologic systems to respond appro-
priately to the individual infecting agent (1). While a potent and
protectiveinnateimmuneresponseisessential,theproinﬂamma-
tory response must be tightly controlled to preclude excessive in-
ﬂammation that may be an even greater threat to the host. In no
situation is this perilous balance between the initiation and reso-
lution of inﬂammation more important than in microbial sepsis.
In septic patients, a disseminated bacterial infection leads to pro-
found morbidity and mortality, resulting in over 200,000 deaths
each year in the United States alone, at an estimated cost of treat-
mentofbillionsofdollars(2).Whilesepsisisamajorpublichealth
threat,nosingletreatmentmodalityhasyetemergedaseffectivein
combating it. The pathobiology of sepsis has proven to be ex-
tremelycomplexbutisbelievedtoinvolveaninitialacutephaseof
hyperinﬂammation initiated by elements of the innate immune
system, including macrophages and neutrophils (3). This proxi-
mal innate response, in many instances, is initiated by a set of
innate immune receptors, the Toll-like receptors (TLRs), which
sense and respond to the unique chemistries of various microbial
constituents. The molecular signatures of infection detected by
differing TLRs are widely varied and include common structural
components of Gram-positive bacteria, Gram-negative bacteria,
viruses, and extracellular parasites. Direct or indirect ligation of
TLRs by these conserved microbial structures initiates activation
of multiple signal transduction cascades, communicated through
a shared set of intracellular adapter proteins. Recruitment of spe-
ciﬁc kinases to the growing TLR-adapter receptor complex ini-
tiates induction of proinﬂammatory cytokines such as tumor ne-
crosis factor alpha (TNF-) and interleukin-1 (IL-1), believed
to be important in septic disease. Perhaps as a safeguard against
thedeleteriousconsequencesthatmassiveTLRligationmayelicit,
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system(i.e.,macrophagesandneutrophils)toTLRligandsresults
inatransientstateofrefractorinesstosubsequentstimulationthat
is known as “tolerance.”
Toleranceisconsideredimportantinvivoinhumaninfections
because circulating monocytes and macrophages from septic in-
dividuals display many of the same refractory phenotypes upon
TLR agonist stimulation, as seen in in vitro restimulation experi-
ments (4–7). In fact, the effects of sepsis-induced tolerance may
persistforyearsfollowingtheclearanceoftheinitialinfectionand
may underlie the dramatically increased morbidity and mortality
seen in postsepsis patient groups when compared to normal con-
trols (8, 9).
Lipopolysaccharide (LPS)-induced tolerance does not, how-
ever,resultintheglobalinhibitionofTLR-inducedinﬂammatory
gene expression (10), and this observation led to the concept of
macrophage “reprogramming” (11, 12) rather than “tolerance.”
Since these early reports, the vast majority of studies that have
soughttounraveltheeffectsoftolerance/macrophagereprogram-
ming have focused on the molecular mechanisms by which TLR
signal transduction is altered or blocked in tolerance, and a few
key aspects of this negative regulation have emerged. Speciﬁcally,
ithasbeenshownthattheproximalTLR4-associatedsignaltrans-
duction complex is not as robustly assembled in response to LPS
in tolerance (13). This may, in part, result from the fact that key
posttranslational modiﬁcations, e.g., phosphorylation, to TLR4
donotoccurintolerizedcells(14).Anothercriticalmechanismby
which signal transduction is inhibited in tolerance is the upregu-
lation of negative regulators of signaling, e.g., IRAK-M. IRAK-M
is a catalytically inactive member of the IRAK kinase family that
preventsformationofIRAK-1–TRAF6complexesdownstreamof
TLR4 (15, 16). Contrary to the upregulation of IRAK-M, the crit-
ical signaling kinase, IRAK-1, is downregulated at the levels of
protein and RNA in endotoxin-tolerant macrophages (17, 18).
Direct remodeling of chromatin at target genes to prevent or po-
tentiatetranscriptionalupregulation(19)hasalsobeenimplicated
as yet another mechanism by which tolerance is enforced. Inter-
estingly, two reports have suggested that a ubiquitin ligase,
SOCS-1, is involved in tolerance because tolerized SOCS-1-
deﬁcient macrophages display increased inﬂammatory cytokine
production in comparison to that displayed by naive, tolerized
macrophages (20). Nonetheless, despite the fact that endotoxin
tolerance has been studied for more than 60 years, neither a clear
understandingofitsinductionnortheimpactofTLRtoleranceon
disease has emerged.
ProteinkinaseR(PKR)isaserine/threoninekinasebestknown
as a regulator of protein translation activated by viral RNA in the
cytosol (21–23). However, PKR has also been shown to be acti-
vated by LPS through TLR4 (24–26), although the precise role of
PKRinmediatingtheresponsetoendotoxinisnotclear.Ininves-
tigatingtheTLR4-mediatedregulationofPKR,wediscoveredthat
PKR itself was a target of macrophage reprogramming and was
negatively regulated in endotoxin-tolerized cells.
Ubiquitination (Ub) plays an important role in regulating sig-
nal transduction downstream of TLR engagement. Both classical,
proteolytic Ub, resulting from the attachment of ubiquitin mole-
cules concatenated into chains by linking monomers one to the
nextvialysine48(K48),andnoncanonical,nonproteolyticchains,
utilizinglysine63(K63)linkages,arecriticalinTLRsignaling(27,
28). The K63 Ub of signaling intermediates, such as IRAK-1 by
TRAF6and/orPellinofamilymembers,facilitatestheassemblyof
higher-ordersignalingcomplexesthatleadtotheactivationofthe
transcription factor NF-B (29, 30). Conversely, the K48 ligation
of signaling elements, such as the adapter protein TIRAP/Mal, is
thought to limit signaling (31). Differential Ub of the same mole-
cule, leading to distinct signaling outcomes, was ﬁrst coined
“ubiquitinediting”byLamandcolleaguestodescribequantitative
changes in ubiquitination (32) and was subsequently adopted by
NewtonandcolleaguestodescribetheregulationofIL-1-induced
IRAK-1 (33). Interestingly, those authors also showed that Ub of
signaling proteins may not be static or restricted to either K48 or
K63 chains but may, in some instances, be a dynamic process that
balancestheexpressionofthesetwochainspecies,leadingtoﬁne-
tuning of the innate response (33). The data presented herein
supporttheinvolvementof“ubiquitinediting”ininnatesignaling
and as a unique mechanism of PKR inactivation in endotoxin
tolerance.
RESULTS
Giventhatthechangesthatoccurinsignaltransductionpathways
in TLR-tolerized or -reprogrammed macrophages are incom-
pletelydescribed,itisofimportancetocharacterizemorefullythe
regulation of TLR-responsive kinases in these states. The serine/
threonine kinase PKR has been demonstrated by multiple inves-
tigators to be activated downstream of TLR4 engagement and has
beenshowntoplayaroleinshapingtheresponsetoLPS(24–26).
However, little work has been done on the capacity of TLRs other
than TLR4 to activate PKR or on the molecular determinants of
PKR activation by TLRs in general. To address this gap in our
understanding, we initially sought to characterize the kinetics of
PKRactivitydownstreamofmultipleTLRsinnaivemacrophages.
Primaryperitonealmacrophageswerestimulatedwithligandsfor
TLRs that differentially utilize different adapter combinations
(e.g., TLR2 [TIRAP/MyD88], TLR3 [TRIF only], or TLR4
[TIRAP/MyD88 and TRAM/TRIF]) over a 90-min time course,
and the activation of PKR was measured by phosphospeciﬁc
Western analysis (Fig. 1). We observed rapid activation of PKR in
responsetoLPS,withkineticsofphosphorylationthatcloselymir-
rored that of the mitogen-activated protein kinase (MAPK)
ERK1/2 (Fig. 1, left). Interestingly, we did not observe substantial
PKR activation by the TLR2 ligand S-[2,3-bis(palmitoyloxy)-(2-
RS)-propyl]-N-palmitoyl-(R)-Cys-Ser-Lys4-OH (P3C), and its
ability to induce ERK phosphorylation was slightly delayed and
FIG1 PKRisdifferentiallyactivatedbydistinctTLRs.Primarythioglycolate-
elicited macrophages were treated for the indicated times with either E. coli
LPS (250 ng/ml), P3C (500 ng/ml), or p(I · C) (50 g/ml). At the indicated
times, whole-cell lysates were subjected to Western analysis and probed with
antibodiesdirectedagainstphosphorylatedortotalproteinpopulations.These
data are representative of 6 independent experiments.
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ligand poly(I · C) [p(I · C)] also activated PKR (Fig. 1, right) but
exhibiteddelayedanddiminishedERK1/2activationcomparedto
that exhibited by LPS. As expected, the transcription factor IRF-3
was phosphorylated downstream of both TLR3 and -4 but not
TLR2,withLPSbeingastrongeractivator.Detectionofequivalent
levels of total PKR and p38 indicate equivalent levels of protein
loading.
Since PKR activation has not been examined in TLR-
reprogrammed macrophages, we next examined PKR activation
in macrophages that were ﬁrst incubated for 18 h with medium
alone, or with the TLR4 agonist LPS, and then stimulated for a
90-mintimecoursewithadoseofEscherichiacoliLPSidenticalto
that used in Fig. 1 (250 ng/ml). We conﬁrmed that PKR was acti-
vated by LPS stimulation in naive, medium-pretreated macro-
phages (Fig. 2, naive). Notably, total PKR protein levels were sig-
niﬁcantly elevated in LPS-reprogrammed macrophages, with a
commensurate increase in basal phospho-PKR (p-PKR) levels
(Fig.2,LPStolerized).However,restimulationoftolerantmacro-
phagesproducednoLPS-inducibleincreaseinPKRphosphoryla-
tion (Fig. 2). As it is possible that tolerant macrophages may sim-
ply exhibit delayed kinetics of PKR activation, additional time
courses of activation to 180 min were carried out, with no LPS-
mediated increase in PKR activity (data not shown). To compare
the behavior of PKR under naive and reprogrammed conditions
to that of other previously examined TLR-responsive signaling
pathways, we also measured the activation levels of ERK1/2 and
IRF-3. LPS pretreatment completely ablated LPS-induced ERK
signaling, as previously reported (34) (Fig. 2). IRF-3 activation
was similarly ablated in LPS-tolerized cells (Fig. 2).
After this initial characterization of PKR responsiveness to
TLRs in naive and TLR-reprogrammed macrophages, we sought
toelucidatethemechanismbywhichLPS-inducedPKRactivation
was lost in reprogrammed macrophages. We had reproducibly
observed a modest decrease in PKR total protein levels in LPS-
tolerized macrophages following subsequent restimulation with
LPS, with kinetics that began close to the time of the peak of PKR
activity in naive cells (approximately 45 min) (Fig. 2). This LPS-
inducible loss of total PKR protein was also observed in the LPS-
pretreated RAW 264.7 macrophage cell line (Fig. 3A). The simi-
larityinkineticsbetweenthelossofLPS-induciblePKRactivation
in tolerant cells between 30 and 90 min following LPS restimula-
tion and the reduction of PKR total protein levels over the same
period led us to hypothesize that induced degradation of PKR in
tolerance may, in part, be responsible for the failure to observe
PKR activation.
Given that there is rapidly expanding literature demonstrating
a role for ubiquitin/proteosome-mediated proteolysis in regulat-
ingTLRsignaling(27,35),wenextexploredarolefortheproteo-
some in inhibiting PKR activation in tolerance. In initial experi-
ments, two populations of RAW 264.7 cells were tolerized
overnight with 10 ng/ml E. coli LPS. Eighteen hours later, one set
was pretreated for 30 min with vehicle alone (dimethyl sulfoxide
[DMSO]) as a control, and the other was pretreated for 30 min
with the proteosome inhibitor MG132 at 25 M. After pretreat-
ment with vehicle or MG132, both macrophage populations were
washed and restimulated with LPS (250 ng/ml), and cell lysates
were harvested at the indicated time points (Fig. 3A). As expected
from the results of Fig. 2, activation of PKR, measured by phos-
phorylation, was weak in the vehicle-treated, LPS-tolerized cells,
and the level of total PKR was markedly reduced after 45 min of
LPS treatment. Strikingly, proteosome inhibition by MG132 re-
stored LPS-induced PKR activation in endotoxin-tolerized mac-
rophages and prevented the inducible loss of PKR protein
(Fig. 3A, top and middle, respectively). Proteosome inhibition
also appeared to increase the kinetics by which PKR is inactivated
(Fig. 3A), as judged by the ratio of total PKR to phosphorylated
PKRat90min.Thismaybeduetoamorerapidnegativefeedback
resulting from greater PKR signaling in the MG132-treated cells.
This result is consistent with a role for ubiquitin-mediated prote-
olysis in preventing PKR activation in endotoxin tolerance.
Since a role for differential Ub in endotoxin tolerance had not
been described previously, we further explored this possibility.
PKRactivityhasnotheretoforebeenshowntoberegulatedbyUb.
Therefore, we initially sought to assay more directly for LPS-
induced ubiquitination of PKR. To do this, endogenous PKR was
immunoprecipitated from lysates of medium-pretreated (naive)
or LPS-pretreated (tolerized) RAW 264.7 cells after primary or
secondary stimulation with LPS, respectively. Immunoprecipi-
tates were washed with buffer containing 2 M urea to prevent
contaminationbynonspeciﬁcallybindingubiquitinatedproteins,
subjected to gel electrophoresis, and immunoblotted with mono-
clonal antibody directed against ubiquitin (Fig. 3B and C). Basal
levels of polyubiquitinated PKR were barely detectable in naive
RAW 264.7 macrophages, but rapid and robust high-molecular-
weight, ubiquitinated PKR was detected 15 min after LPS stimu-
lation and persisted until 90 min (Fig. 3B). In contrast, in the
LPS-tolerized macrophages, LPS-inducible Ub of PKR was de-
layed in kinetics and lessened in intensity in comparison to naive
cells(Fig.3C).TotalimmunoprecipitablePKRproteinlevelswere
not signiﬁcantly altered over time in naive cells (Fig. 3B and C).
This result was surprising because our previous observation that
proteosome inhibition could restore activation in tolerance
(Fig. 3A) had led us to expect that PKR would be inducibly ubi-
FIG 2 PKR activation is differentially regulated in TLR-tolerized macro-
phages. Primary murine macrophages were treated overnight with medium
alone (naive) or 10 ng/ml LPS (LPS tolerized). Following pretreatment, cells
were washed and restimulated with LPS (250 ng/ml) for the indicated times.
Whole-cell lysates were subjected to Western analysis and probed with anti-
bodies directed against the indicated total or phosphospeciﬁc species. These
data are representative of 3 independent experiments.
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quent degradation and, thus, explaining the failure in observing
PKR activation in tolerized macrophages. The fact that PKR dis-
plays greater total ubiquitination in naive cells led us to hypothe-
size that there may be qualitative differences in the types of ubiq-
uitin chains attached to PKR in naive versus tolerant states rather
than merely quantitative differences.
Recent studies have suggested that TLR signaling intermedi-
atesaremodiﬁedbyubiquitinchainsthroughK48orK63linkages
thatleadtonegativeorpositiveregulation,respectively.Todelin-
eateifPKRisdifferentiallymodiﬁedbytheseubiquitinchaintypes
in naive versus tolerized cells, we ﬁrst utilized an overexpression
system in the HEK293T cell line. V5-tagged wild-type (WT) PKR
was overexpressed in HEK293T cells, along with expression vec-
tors for WT hemagglutinin (HA)-tagged ubiquitin (HA-Ub) or
HA-taggedubiquitinbearingasinglelysineateitherposition48or
63 (HA-K48 only or HA-K63 only). Twenty-four hours later, V5-
PKR was precipitated from whole-cell lysates, and the immuno-
precipitates were subjected to Western blot analysis with anti-HA
monoclonal antibody. A high-molecular-weight, ubiquitinated
PKR species was detected only when im-
munoprecipitated PKR was coexpressed
with HA-tagged ubiquitin (Fig. 4A). Sig-
niﬁcant Ub of PKR upon cotransfection
witheachofourubiquitinconstructswas
observed, indicating that PKR can be
modiﬁed by both K48 and K63 chains
and holding out the possibility that PKR
activity may be both positively and nega-
tively regulated by Ub. Much of the work
that has been done to describe a role for
K48 or K63 ubiquitin chains in signaling
hasbeendonewithexperimentalsystems
involvingoverexpressionofpotentialtar-
gets and/or ligases. Such systems have
yielded signiﬁcant insights but carry with
them potential for artifactual interac-
tions. In an effort to circumvent such is-
sues, we initially sought to demonstrate
LPS-dependentK48and/orK63ubiquiti-
nation of PKR in cell lines. Naive or LPS-
tolerantRAW264.7cellswerestimulated
with LPS, and proteins from whole-cell
lysates speciﬁcally modiﬁed by K63 Ub
chains were immunoprecipitated, utiliz-
ing a monoclonal antibody speciﬁc for
K63chains.Immunoprecipitateswerere-
solved by polyacrylamide gel electro-
phoresis (PAGE) and probed with a
monoclonal antibody against PKR
(Fig.4B).LPSinducedrapidK63modiﬁ-
cationofPKRinnaiveRAWcellsbutnot
in LPS-tolerant cells. Interestingly, the
anti-K63 Ub monoclonal antibody pre-
cipitated PKR as a single species, perhaps
indicating that in response to LPS, PKR
undergoes a single K63 modiﬁcation. As
thereisnocommerciallyavailablemono-
clonal antibody that will speciﬁcally pre-
cipitate K48 chains, we initially at-
tempted to transfect our HA-tagged K48-only or K63-only
expression constructs into RAW 264.7 cells and immunoprecipi-
tate endogenous PKR following LPS stimulation to observe HA
tag modiﬁcation. These experiments were unsuccessful, presum-
ablyduetotheextremelylowtransfectabilityofthiscellline(data
not shown). As an alternate approach, we established an experi-
mental system utilizing a readily transfectable derivative of the
HeLacelllinethatstablyexpressesTLR4andMD-2(MAT4).This
cell line has been previously reported to respond authentically to
stimulationwithLPS(36),andinourhands,thiscelllineexhibits
a loss of LPS-dependent ERK activation following prolonged ex-
posuretoLPS,ahallmarkoftolerance(Fig.4E).Toassesstherole
of lysine-speciﬁc Ub in this context, MAT4 cells were transiently
transfected with the mutant construct that encodes the HA-K63-
onlyubiquitinandthenstimulatedovernightwitheithermedium
alone or medium supplemented with LPS. Following overnight
incubation, MAT4 cells were washed and then restimulated with
LPS over a 90-min time course, PKR was immunoprecipitated at
15-min intervals, and the immunoprecipitates were subjected to
Western analysis with anti-HA monoclonal antibody. In naive
FIG 3 PKR is inducibly ubiquitinated in tolerized macrophages, and tolerance depends upon a
functional proteosome. (A) RAW 264.7 cells tolerized overnight with LPS (10 ng/ml) were pretreated
for 30 min with either vehicle only (DMSO) or MG132 (25 M). Cells were subsequently stimulated
withLPS(250ng/ml)fortheindicatedtimes.Whole-celllysatesweresubjectedtoWesternanalysisand
probed with the indicated antibodies. (B and C) Naive (B) or LPS-tolerized (C) RAW 264.7 cells were
stimulated with LPS (250 ng/ml), and cells were lysed at the indicated times. PKR was immunoprecipi-
tated from cell lysates, and immunoprecipitating complexes were subjected to SDS-PAGE. Separated
complexes were sequentially probed with a monoclonal antibody directed against ubiquitin and a
monoclonal antibody against PKR. Data are representative of 3 independent experiments. IB, immu-
noblotting.
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ics that closely mirrored that of PKR phosphorylation (Fig. 4C).
Remarkably, this ubiquitin modiﬁcation was undetectable by this
assay in LPS-tolerized cells, indicating for the ﬁrst time an alter-
ation of the Ub of a TLR signaling element in LPS-tolerant cells.
TheidenticalexperimentcarriedoutusingtheHA-K48ubiquitin
mutantrevealedaK48ubiquitinationofPKRinnaiveMAT4cells
(Fig.4D).Differentially,K48ubiquitinationofPKRwasenhanced
in both kinetics and intensity in the LPS-tolerized MAT4 cells
(Fig. 4D).
Because our data strongly suggest that ubiquitin-mediated
proteolysisplaysaroleintheinactivationofPKRinLPS-tolerized
cells,wenextsoughttoascertaintheidentityoftheK48ligasethat
is responsible. Among the LPS-inducible K48 ligases, the SOCS
family of ubiquitin ligases has been linked extensively to the neg-
ative regulation of cytokine and inﬂam-
matory processes (37). In particular,
SOCS-1 is upregulated by LPS and has
been reported to catalyze the destruction
of proximal elements of TLR signal com-
plexes (31). In addition, SOCS-1-
deﬁcient mice have been reported to be
impaired in their capacity to induce en-
dotoxin tolerance (20, 38), although oth-
ers have reached different conclusions in
regard to a role for SOCS-1 as a mediator
of tolerance (39). We examined the
steady-state levels of SOCS-1 by Western
analysis of both naive macrophages and
macrophages that had been rendered tol-
erant by preincubation with medium
only or with LPS, P3C, or p(I · C). In the
naive state, SOCS-1 protein levels were
comparativelylow(Fig.5A).However,in
tolerant macrophages, SOCS-1 levels
were signiﬁcantly elevated regardless of
stimulus used (Fig. 5A). We therefore in-
vestigated the possibility that PKR and
SOCS-1 interact functionally in vitro, re-
sulting in K48 Ub of PKR. To test this
hypothesis, PKR was overexpressed in
HEK293T cells, along with increasing
concentrations of a SOCS-1 expression
vector. We observed a striking dose-
dependent reduction in basal PKR pro-
tein expression levels in response to an
increase in SOCS-1 following 24 h of in-
cubation (Fig. 5B, top). This was not the
resultofwidespreadnonspeciﬁcdegrada-
tion of TLR4-responsive kinases because
endogenous levels of the TLR-responsive
MAPK p38 were not reduced, even at the
highest levels of transfected SOCS-1
(Fig. 5A, bottom). Since overexpression
ofK48ligasescan,insomeinstances,lead
to a loss of target speciﬁcity, we repeated
this experiment using a closely related
family member, SOCS-2, in lieu of
SOCS-1. Importantly, SOCS-2 overex-
pression had a negligible effect on the
basal level of PKR, even at the highest dose (Fig. 5C). Since the
effects of SOCS-1 on PKR protein levels may be the result of reg-
ulationofanintermediateelement,weevaluatedthepotentialfor
SOCS-1andPKRtointeractphysicallyinouroverexpressionsys-
tem. V5-tagged WT PKR was transfected into HEK293T cells
without or with concomitant transfection of FLAG-tagged
SOCS-1, and immunoprecipitations were carried out with anti-
FLAG monoclonal antibody. PKR was immunoprecipitated only
in the presence of cotransfected SOCS-1 (Fig. 5D, top). Western
analysis of whole-cell lysates revealed the expected reduction in
PKR expression levels when coexpressed with SOCS-1 (Fig. 5D,
bottom). The capacity of SOCS-1 to interact physically with and
catalyze degradation of PKR in HEK293T cells supports the pos-
sibilitythatSOCS-1regulatesPKRproteinlevelsduringtheTLR4-
mediated response to LPS. To assay for the potential in vivo sig-
FIG 4 PKR undergoes K63 and K48 ubiquitination in response to LPS. (A) HEK293T cells were
transfected with cDNA constructs expressing V5-tagged wild-type (WT) PKR and/or HA-tagged WT
ubiquitin, HA K63-only Ub, or HA K48-only Ub. Twenty-four hours later, cells were lysed, and PKR
was immunoprecipitated from whole-cell lysates. Immunoprecipitates were subjected to SDS-PAGE
and probed with monoclonal antibody against HA. (B) Raw 264.7 cells were incubated overnight with
medium alone or 100 ng/ml of LPS. Cells were washed and restimulated with 250 ng/ml LPS for the
indicated times. Immunoprecipitation was carried out with anti-K63 Ub chain monoclonal antibody.
(C and D) MAT4 cells were transfected with cDNA constructs expressing either K63-only HA-tagged
Ub (C) or K48-only HA-tagged Ub (D) and immediately treated overnight with medium alone or
100 ng/ml LPS. Eighteen hours following primary treatment, cells were washed and stimulated with
250 ng/ml LPS, PKR was immunoprecipitated from whole-cell lysates, and immunoprecipitates were
subjected to SDS-PAGE, followed by probing with anti-HA monoclonal antibody. (E) Naive (N) or
LPS-tolerized (T) MAT4 cells were restimulated with 250 ng/ml LPS, and phospho-ERK levels were
assayed by Western blotting. These data are representative of 4 independent experiments.
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SOCS-1 knockout mouse embryonic ﬁbroblasts (MEFs) and as-
certained LPS-responsive PKR activation in naive and LPS-
tolerized cells. Stimulation of wild-type, naive MEFs produced a
modest and transient activation of PKR (Fig. 5E). Remarkably,
PKRactivitywasdramaticallyenhancedandmaximalinunstimu-
latedSOCS-1/MEFsandcouldnotbefurtherenhancedbyLPS
treatment at any dose used, demonstrating a role for SOCS-1 in
regulating PKR activity (Fig. 5E). In LPS-tolerized MEFs, how-
ever, PKR activity could not be stimulated by LPS in either the
SOCS-1/ or SOCS-1/ genotype, suggesting that a combina-
tion of mechanisms play a role in enforcing PKR tolerance
(Fig. 5F).
DISCUSSION
While the clinical importance of sepsis as a major public health
issue has long been recognized, our understanding of the molec-
ular biology of this condition has signiﬁcantly lagged behind, and
despiterepeatedefforts,newpalliativeoptionsfortreatmenthave
not been forthcoming. This may, in part,
result from the fact that sepsis reﬂects a
complex interplay between the host im-
mune response and the invading patho-
gen. Host macrophages activated
through innate immune surveillance re-
ceptors,suchasTLRs,areinstrumentalin
the pathology of sepsis, as evidenced by
the adaptive phenomenon of TLR-
induced macrophage reprogramming.
Indeed, the initiation of a tolerized state
of the innate immune system is not lim-
ited exclusively to TLRs, as an analogous,
although distinct, tolerance results after
prolonged ligation of other signaling re-
ceptors, including the IL-1 receptor (13)
and NOD-like receptors (NLRs) (40). In
an attempt to expand our understanding
ofsignalingintolerance/reprogramming,
wehavediscoveredthatPKR,shownpre-
viously to be activated by LPS, is an addi-
tional signaling element that is subject to
tolerance. Although the canonical model
forPKRactivationrequiresitsinteraction
with exogenous RNAs not known to be
produced downstream of TLR ligation,
multiple studies have reported roles for
PKR in the cellular response to LPS. Spe-
ciﬁcally, PKR was shown to interact di-
rectly with the TLR4 adapter TIRAP/Mal
and to exhibit a partial dependence on
MyD88 for activation through TLR4
(24). Delineation of the precise TLR-
inducible signaling complexes leading to
PKR activation will be a compelling ave-
nue for investigation and should expand
ourunderstandingofTLRsignaling.One
candidate intermediary for linking TLRs
to PKR activation is the PKR-interacting
protein PACT/RAX, known to activate
PKR under diverse conditions of cellular
stress independently of RNA (41, 42).
OurresultsshowthatPKRactivationisnotafeatureofallTLRs,as
evidencedbythefactthatPKRisactivatedbyTLR4andTLR3but
not by TLR2. We also show that total PKR levels are elevated in
LPS-tolerant murine macrophages but not in MEFs, a fact that
may reﬂect the far greater LPS sensitivity of macrophages com-
pared to that of embryonic ﬁbroblasts.
Our observations are the ﬁrst to provide a link between post-
translational modiﬁcation of signaling elements by Ub and the
differential regulation of signaling in tolerance (see Fig. 6). Given
thesigniﬁcantandexpandingroleplayedbyUbinregulatingTLR
signaling,itishighlyunlikelythatPKRistheonlysuchelementto
undergonegativelyregulatingshiftsinpatternsofUbintolerance/
reprogramming.Assuch,weprovideevidenceforanewparadigm
intolerancethatmayconceivablyworkinconjunctionwithother
recentlydescribedmechanisms.Forexample,Medzhitovandcol-
leagues recently described selective chromatin remodeling in
endotoxin-tolerizedmacrophagesasameanstorendersomepro-
moters“tolerizable”whileleavingothersresponsivetoLPS(19).It
FIG 5 SOCS-1 physically interacts with and negatively regulates PKR. (A) Primary peritoneal macro-
phages were stimulated for 18 h with medium (M), LPS (10 ng/ml), P3C (100 ng/ml), or p(I · C)
(10g/ml).Cellswereharvested,andthelevelsofSOCS-1proteinwereexaminedbyWesternanalysis.
(B and C) HEK293T cells were transfected with 200 ng V5-tagged WT PKR and either empty vector or
an increasing amount of cDNA expressing FLAG-tagged SOCS-1 (B) or SOCS-2 (C). Twenty-
fourhoursfollowingtransfection,whole-celllysatesweresubjectedtoWesternanalysiswithantibodies
againsttheindicatedspecies.(D)HEK293TcellstransfectedwithV5-PKRaloneorinconjunctionwith
FLAG-tagged SOCS-1. Cell lysates were immunoprecipitated with anti-FLAG antibody and separated
by SDS-PAGE, followed by Western blotting with the indicated antibodies. These data are representa-
tive of 3 independent experiments. (E and F) WT and SOCS-1/ MEFs were cultured overnight in
mediumalone(E)orinmediumsupplementedwithLPS(100ng/ml)(F).Following18hoftreatment,
cells were washed and restimulated with LPS (250 ng/ml) for the indicated times. Whole-cell lysates
were resolved by SDS-PAGE and probed with antibodies against phosphorylated or total PKR. These
data are representative of 3 independent experiments.
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K63 Ub versus K48 Ub of key downstream signaling molecules
reduces TLR signal strength, further exacerbating the effect of
chromatin remodeling. In a previous report by Newton and col-
leagues, sequential waves of K63 Ub, followed by K48 ubiquitin
modiﬁcations, were induced on IRAK1, following ligation of the
IL-1 receptor (33). The present work is, to our knowledge, only
the second example of rapid ubiquitin editing/switching of Ub in
innatesignalingandtheﬁrstexampleinthecontextofTLRs(33).
Whether a deubiquitinating enzyme such as A20 plays any role in
ubiquitin switching in the context of PKR remains to be deter-
mined. Our data also expand the concept of ubiquitin editing to
show that it is not necessarily a static balance but, rather, that the
ratios of K63 to K48 chains added to a given kinase during signal-
ingmayshiftwithcellularcontext,ashiftthatmayhaveprofound
consequences on the behavior of signal-transducing intermedi-
ates and, thus, the immune response. Additional studies will be
requiredtodetermineifanalteredK63versusK48balance,asseen
inmacrophagereprogramming,isalsoimportantinotherscenar-
ios beyond endotoxin tolerance.
Finally,weprovideevidenceforPKRbeinganadditionaltarget
for SOCS-1, thereby expanding its role as a critical regulator of
TLR4signaling.LossofSOCS-1resultsinconstitutivePKRhyper-
activityinnaivecells,evenintheabsenceofLPSstimulation.Why
alossofSOCS-1resultsindramaticallyandconstitutivelyelevated
levels of phosphorylated PKR, but not total PKR, is not entirely
clear.OnepossibleexplanationisthatSOCS-1interactsonlywith
and negatively regulates the phosphorylated/activated pool of
PKR protein. This hypothesis is supported by the published ob-
servation that SOCS-1 requires its SH2 domain to interact with
phosphotyrosine residues on target proteins to function as a li-
gase. It is also important to point out that while the residue de-
tectedbythephosphospeciﬁcantibodywehaveusedstronglycor-
relateswithPKRactivity,formalmeasurementofkinaseactivityin
SOCS-1 knockout MEFs has not been done. Nevertheless, the
elimination of SOCS-1 alone did not restore LPS responsiveness
intolerantMEFs.Thisisperhapsnotentirelysurprising,aswealso
observedalossofLPS-dependentK63Ubintolerance,whichmay
be a redundant mechanism to negatively govern PKR
MATERIALS AND METHODS
Cells and reagents. Primary peritoneal macrophages were prepared as
described previously (43). Brieﬂy, 3 ml of 3% sterile ﬂuid thioglycolate
(Remel) was injected intraperitoneally (i.p.) into 6- to 8-week-old, wild-
type (WT) C57BL/6J mice (Jackson Laboratories, Bar Harbor, ME).
Four days later, macrophages were harvested by peritoneal lavage with
sterile saline.
HEK293T (ATCC, Manassas, VA) cells were cultured in Dulbecco
modiﬁed Eagle medium (DMEM; BioWhittaker) supplemented with
10% fetal bovine serum (FBS), 2 mM L-glutamine, 100 U/ml penicillin,
and 100 g/ml streptomycin. The RAW 264.7 macrophage-like cell line
(ATCC) was cultured in RPMI 1640 (BioWhittaker) supplemented with
10% FBS, 2 mM L-glutamine, 100 U/ml penicillin, and 100 g/ml strep-
tomycin.TheMAT4celllinethatstablyexpresseshumanTLR4andMD-2
(a kind gift from Liwu Li, Virginia Tech University, Blacksburg, VA) was
maintained in DMEM supplemented as described for HEK293T cells.
Wild-typeandSOCS-1knockoutﬁbroblastswereakindgiftfromAtsushi
Okumura(UniversityofPennsylvaniaVeterinarySchool)andweremain-
tained in DMEM.
Protein-free, phenol-water-extracted Escherichia coli K235 LPS was
prepared as described elsewhere (43). The TLR2 ligand S-[2,3-
bis(palmitoyloxy)-(2-RS)-propyl]-N-palmitoyl-(R)-Cys–Ser–Lys4-OH
(P3C) was obtained from EMC Microcollections (Tübingen, Germany).
TheTLR3agonistpoly(I·C)wasobtainedfromSigma-Aldrich(St.Louis,
MO).MG132waspurchasedfromCalbiochem(Gibbstown,NJ)andwas
resuspended in DMSO, according to the manufacturer’s instructions.
Monoclonal antibody to PKR (clone B-10) and polyclonal antibody to
SOCS-1 were purchased from Santa Cruz Biotechnology (Santa Cruz,
CA). Phosphospeciﬁc anti-PKR antibody was purchased from BioSource
(Carlsbad, CA). Antiubiquitin (clone PD4) and anti-p38 antibodies were
obtained from Cell Signaling (Danvers, MA). Anti-HA monoclonal anti-
bodywaspurchasedfromRoche(Indianapolis,IN).Anti-V5monoclonal
antibodywasobtainedfromInvitrogen(Carlsbad,CA).Anti-K63mono-
clonal antibody was obtained from Biomol (Plymouth, PA). Expression
vectorsencodingHA-taggedWT,K63-only,andK48-onlyubiquitinwere
kindlyprovidedbyYixianZheng(CarnegieInstituteofWashington)and
were described elsewhere (44). A V5-tagged PKR plasmid was a kind gift
from Ganesh Sen (Lerner Research Institute, Cleveland Clinic). Expres-
sionplasmidsforFLAG-taggedSOCS-1andSOCS-2werekindgiftsfrom
Raymond Donnelly (FDA, Bethesda, MD).
Stimulation and induction of tolerance in primary macrophages.
For primary stimulation experiments, primary peritoneal macrophages
were plated at a density of 4  106 cells per well in a six-well plate and
treated with TLR ligands for the indicated time periods at the following
ﬁnalconcentrations:LPS,250ng/ml;P3C,500ng/ml;andp(I·C),50g/
ml. Doses of individual TLR ligands were selected after optimizing the
experimental conditions. Cells were harvested in lysis buffer (20 mM
HEPES,1.0%TritonX-100,0.1%sodiumdodecylsulfate[SDS],150mM
NaCl, 10 mM NaF, 1 mM phenylmethylsulfonyl ﬂuoride [PMSF]), and
the lysates were used for Western analyses with described antibodies.
Forexperimentsinvolvingtolerance,macrophageswereincubatedfor
18 h with medium, 100 ng/ml LPS, 100 ng/ml P3C, or 10 g/ml p(I · C),
washed extensively with phosphate-buffered saline (PBS), and restimu-
lated with 250 ng/ml LPS for the indicated times.
Transfection of HEK293T cells and Western blot analysis. Whole-
cell lysates from treated HEK293T cells, RAW 264.7 cells, or primary
murine macrophages were obtained after the cells were washed twice in
PBS by the addition of lysis buffer (20 mM HEPES, 1.0% Triton X-100,
0.1% SDS, 150 mM NaCl, 10 mM NaF, 1 mM PMSF) and subsequent
incubation at 4°C. Cell lysates were separated by electrophoresis in a de-
naturing SDS-PAGE gel and by subsequent transfer to a polyvinylidene
diﬂuoride(PVDF)membrane.Blotswereincubatedovernightinrelevant
primary antibodies at 4°C, washed 3 times with PBS, and then incubated
with the appropriate horseradish peroxidase (HRP)-conjugated second-
aryantibody(JacksonImmunochemicals,ME).Blotsweredevelopedfol-
FIG 6 Schematic summary of results. Model representing differential PKR
ubiquitination in naive or LPS-tolerized macrophages and the consequences
for LPS-induced PKR activity.
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ersham Biosciences, Piscataway, NJ).
Ubiquitin immunoprecipitations. To determine the ubiquitination
status of PKR in RAW 264.7 cells, immunoprecipitation (IP) was per-
formed as follows. A total of 3  106 cells were plated per well in a 6-well
tissuecultureplateandtreatedwithmediumonlyor100ng/mlE.coliLPS.
Eighteenhourslater,cellswerewashedtwiceinPBS,andthemediumwas
replaced. Cells were restimulated with 250 ng/ml E. coli LPS, and individ-
ual wells were harvested at various time points in lysis buffer (20 mM
HEPES, 1% Triton X-100, 0.1% SDS, 150 mM NaCl). Total lysates were
preclearedwithproteinAgel(Sigma)for30min,andPKRwasimmuno-
precipitatedwith1gofanti-PKRmonoclonalantibody(cloneB10)and
additionalproteinAgelfor2hat4°C.Immunecomplexeswerewashed3
times with 1 ml of lysis buffer, followed by being washed once in lysis
buffer supplemented with 1 M urea (Sigma). Immunoprecipitated pro-
teinswereseparatedbySDS-PAGE,transferredtoPVDFmembranes,and
probed for the presence of ubiquitinated PKR using antiubiquitin mono-
clonal antibody. For analysis of ubiquitination in HEK293T, 7.5  105
cells were plated in 6-well plates and transfected the following morning
with constructs expressing tagged PKR and/or constructs expressing HA-
taggedubiquitin.Twenty-fourhoursaftertransfection,cellswerelysedin
lysis buffer and precipitated with 1 g of anti-V5 antibody. Immunopre-
cipitates were probed with anti-HA monoclonal antibody.
Transfection of and immunoprecipitation from MAT4 cells. MAT4
cellswereplatedatadensityof5105cellsperwellinasix-welldishand
transfected 24 h later with 1 g of empty vector or vector that expresses
eitherHA-K63-onlyorHA-K48-onlyubiquitin.Eighthoursaftertheend
oftransfection,cellswerestimulatedwithmediumaloneormediumcon-
taining 100 ng/ml LPS for an additional 18 h. Cells were then washed 3
times in PBS and stimulated with 250 ng/ml LPS for the indicated times.
Samples from each time point were immunoprecipitated in lysis buffer
with anti-PKR monoclonal antibody, and immunoprecipitates were sep-
arated by SDS-PAGE. Blots were probed with anti-HA monoclonal anti-
bodies as described above.
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